REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/06/2026
Back to search
Official data from USPTO
REVOLLINE GRANDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
REVOLLINE GRANDE
ST13
US500000079294400Class
10
Filing
79294400
Registration
6311495
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/07/2026
Classification
Registered
Trademark type
Word
Nice classes
10
Filing date
07/24/2020
Registration date
04/06/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/06/2021
Last transaction
04/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HUMEDIX Co., Ltd.
Representatives
Jae Youn Kim Novick, Kim & Lee, PLLC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus for injecting fillersmedical filler syringes; syringes for injections; medical apparatus for introducing pharmaceutical preparations into the human body; syringes for medical purposes; surgical robots; surgical instruments and apparatus; artificial skin for surgical purposes; massage apparatus for medical purposes; medical diagnostic apparatus for diagnosing lost collagen in the skin; artificial joints; endoprostheses; artificial breasts; hair prostheses; bone void fillers comprised of artificial materials; medical apparatus and instruments for treating urinary diseases; medical apparatus for treating diseases in the field of obstetrics and gynecology; surgical apparatus and instruments for veterinary use
Publications
History of USPTO decisions and trademark events.
27 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/24/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/08/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/19/2021
FIMP
FINAL DISPOSITION PROCESSED
07/19/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/24/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2021
PUBO
PUBLISHED FOR OPPOSITION
01/19/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/30/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/30/2020
RFNT
REFUSAL PROCESSED BY IB
12/20/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/03/2020
RFRR
REFUSAL PROCESSED BY MPU
12/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/18/2020
CNRT
NON-FINAL ACTION WRITTEN
11/17/2020
DOCK
ASSIGNED TO EXAMINER
11/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/29/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/24/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/24/2020
Continuous trademark protection
Get notified about every new filing that threatens REVOLLINE GRANDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.